Clinical and Radiographic Evaluation of Bioceramic Putty MTA Versus MTA in Pulpotomy of Immature Permanent Molars
NCT ID: NCT06219824
Last Updated: 2024-07-23
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
NOT_YET_RECRUITING
PHASE3
40 participants
INTERVENTIONAL
2024-11-01
2025-11-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The main question it aims to answer is:
Will the biocermaics putty MTA have higher clinical and radiographic success rates than MTA in pulpotomy of immature permanent molars?
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Premixed Bioceramic Putty as an Apical Plug in Immature Anterior Permanent Teeth
NCT06322979
Evaluation of MTA Versus Biodentine as Pulpotomy Agents in Immature First Permanent Molars
NCT03838094
Clinical And Radiographic Evaluation Of Premixed Bio-ceramic MTA In Indirect Pulp Capping Of Young Permanent Molars
NCT05928858
Three Dimensional Evaluation of Apexogenesis of Immature Young Permanent Teeth With Different Endodontic Material
NCT05790629
Clinical and Radiographic Success of Pulpotomy Using Neoputty Mineral Trioxide Aggregate Versus Pulpectomy Using Endoflas In Primary Molars With Irreversible Pulpitis: A Randomized Controlled Trial
NCT06922578
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
MTA has various drawbacks, such as difficulty in handling, long setting time, discoloration of the tooth, and its form as a powder/liquid which raise the responsibility for major material waste. To conquer these issues, bioceramic materials have been developed premixed putty bioceramic MTA is a ready-to-use material for immediate placement with zero waste, saving cost and chair time. Thus, the present study aims to evaluate bioceramic putty MTA's clinical and radiographic success versus MTA in pulpotomy of immature permanent molars.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
control Group
pulpotomy treatment for the young permanent teeth will be done using conventional powder and liquid Mineral Trioxide Aggregate followed by Glassionomer restoration and stainless steel crown
Conventional MTA
pulpotomy treatment will be done and powder and liquid MTA will be mixed and applied in the pulp chamber
Experimental
pulpotomy treatment for the young permanent teeth will be done using premixed ready for use bioceramic MTA followed by Glassionomer restoration and stainless steel crown
premixed Bio-ceramic MTA
pulpotomy treatment will be done and the premixed bioceramic MTA will be applied in the pulp chamber
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
premixed Bio-ceramic MTA
pulpotomy treatment will be done and the premixed bioceramic MTA will be applied in the pulp chamber
Conventional MTA
pulpotomy treatment will be done and powder and liquid MTA will be mixed and applied in the pulp chamber
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* with deep carious lesions indicated for pulpotomy.
* Restorable young permanent molars with no clinical symptoms of irreversible pulpitis.
* Permanent molars without any clinical sign of pulp necrosis including swelling, fistula, pain on percussion, and pathologic tooth mobility.
* Permanent molars without any adverse radiographic findings including thickening of the periodontal ligament space, radiolucency at the interradicular or periapical regions
* permanent molars without internal and external root resorption, or calcification in pulp tissue.
Exclusion Criteria
* Uncooperative patients who refuse treatment.
* Permanent molars that were previously restored.
6 Years
8 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Cairo University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Marwa Abd El-Naby Hussien
Assistant lecturer of Pediatric Dentistry, Faculty of Dentistry, October University for Modern Sciences and Arts
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Cairo university
Cairo, , Egypt
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
14422022599195
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.